Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Peptides
|
August 4, 2009
Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation
Satya P Kalra
Nutrition (Burbank, Los Angeles County, Calif.)
|
August 30, 2008
Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches
Satya P Kalra
Indian Journal of Endocrinology and Metabolism
|
April 9, 2013
A case for new therapy for diabetes, is it leptin?
Satya P Kalra
Indian Journal of Endocrinology and Metabolism
|
November 20, 2013
Should leptin replace insulin as a lifetime monotherapy for diabetes type 1 and 2?
Satya P Kalra
Peptides
|
December 7, 2007
Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions
Satya P Kalra
Current Topics in Medicinal Chemistry
|
November 6, 2007
Global life-long health benefits of repression of hypothalamic NPY system by central leptin gene therapy
Satya P Kalra
EXS
|
December 31, 2005
Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time
Satya P Kalra, Pushpa S Kalra
Endocrine
|
November 12, 2003
Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin
Satya P Kalra, Pushpa S Kalra
Drugs of Today (Barcelona, Spain : 1998)
|
February 13, 2003
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy
Pushpa S Kalra, Satya P Kalra
Journal of Addictive Diseases
|
July 17, 2004
Overlapping and interactive pathways regulating appetite and craving
Satya P Kalra, Pushpa S Kalra
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Peptides
|
August 4, 2009
Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation
Satya P Kalra
Nutrition (Burbank, Los Angeles County, Calif.)
|
August 30, 2008
Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches
Satya P Kalra
Indian Journal of Endocrinology and Metabolism
|
April 9, 2013
A case for new therapy for diabetes, is it leptin?
Satya P Kalra
Indian Journal of Endocrinology and Metabolism
|
November 20, 2013
Should leptin replace insulin as a lifetime monotherapy for diabetes type 1 and 2?
Satya P Kalra
Peptides
|
December 7, 2007
Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions
Satya P Kalra
Current Topics in Medicinal Chemistry
|
November 6, 2007
Global life-long health benefits of repression of hypothalamic NPY system by central leptin gene therapy
Satya P Kalra
EXS
|
December 31, 2005
Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time
Satya P Kalra, Pushpa S Kalra
Endocrine
|
November 12, 2003
Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin
Satya P Kalra, Pushpa S Kalra
Drugs of Today (Barcelona, Spain : 1998)
|
February 13, 2003
Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy
Pushpa S Kalra, Satya P Kalra
Journal of Addictive Diseases
|
July 17, 2004
Overlapping and interactive pathways regulating appetite and craving
Satya P Kalra, Pushpa S Kalra
Page
of 5